An observational study in Low Vision, Retinitis Pigmentosa and Stargardt Disease 1, sponsored by Queen's University, Belfast. Completed at 1 site in United Kingdom. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-10-26.
Sponsored by Queen's University, Belfast · Observational
Purpose:
To validate a newly developed battery of performance-based tests of visual function to be presented using virtual reality. The tests are intended as potential outcome measures for clinical trials of treatments of eye disease: they measure visual performance in patients with low vision on visual tasks that a relevant for daily life.
Aims of the Research Project:
98 studies on the registry are indexed under Vision, Low; 23 are open to participants now.
This study's enrollment of 18 is below the median of 100 across 19 observational studies indexed under Vision, Low.
Browse Vision, Low studies →Queen's University, Belfast is the lead sponsor of 117 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with Stargardt's disease, advanced retinitis pigmentosa and Albinism.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Sight impairment criteria are as follows:
Exclusion Criteria:
Visual task tests based on Oculus Rift
Test repeatability
Bland and Altman analysis will be used to investigate the repeatability of the tests between visit 1 and visit 2.
Time frame: All statistical analysis will take place once all data collection has ended, average 1 year.
Ease of use and acceptability questionnaire
Modified from Tay et al, Br J Ophthalmol 2004;88:719-720 Ask the following questions for virtual reality test: 1. Was the test comfortable? If no- How? 2. Was the test too long? 3. How did you find the test? Would you describe it as easy or difficult? If you found it difficult- how? 4. How would you feel if you knew you had to perform this test at every clinic appointment? 5. Do you have any other comments about the test?
Time frame: Responses from all participants will be collated and summarised at the end of the study, average 1 year.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.